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Abstract 
Background: Oppositional defiant disorder (ODD) is a behavioral disorder of school‑age population. It is well known 
that 5‑HT dysfunction is correlated with impulsivity, which is one of the common characteristics of ODD. The enzyme 
tryptophan hydroxylase‑2 (TPH‑2) synthesizes 5‑HT in serotonergic neurons of the midbrain raphe. The purposes of 
this study were to investigate the potential association of TPH‑2 polymorphisms with susceptibility to ODD in a Han 
Chinese school population.
Methods: Four polymorphisms (rs4570625, rs11178997, rs1386494 and rs7305115) of the TPH‑2 gene were analyzed 
by using polymerase chain reaction and DNA microarray hybridization in a case–control study of 276 Han Chinese 
individuals (124 ODD and 152 controls).
Results: In single marker analyses,there was a significant difference in the genotype (χ2 = 4.163, P = 0.041) 
and allele frequency (χ2 = 3.930, P = 0.047) of rs1386494 between ODD and control groups. Haplotype analyses 
revealed higher frequencies of haplotypes TA (rs4570625‑rs11178997), TAG (rs4570625‑rs11178997‑rs1386494), TAA 
(rs4570625‑rs11178997‑rs7305115) and TAGA (rs4570625‑rs11178997‑rs1386494‑rs7305115), but lower frequencies 
of haplotypes GA (rs4570625‑rs11178997) and GAG (rs4570625‑rs11178997‑rs1386494) in ODD compared to control 
groups.
Conclusions: These findings suggest the role of these TPH‑2 gene variants in susceptibility to ODD. Some haplotypes 
might be the risk factors for Chinese Han children with ODD, while others might be preventable factors.
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Background
Oppositional defiant disorder (ODD) is a behavioral 
disorder mainly characterized by resistance, disobedi-
ence, provocation or hostility to authority figures during 
growth and development in children and adolescents [1, 
2]. Children and adolescents with ODD may have trouble 
controlling their temper, showing intense emotional reac-
tion or impulsive actions in response to mild stimula-
tion. Thus, ODD is considered as a disorder of emotional 
regulation [3]. Children suffering from ODD are at risk 
for numerous negative outcomes, such as delinquency, 
unemployment, depression, anxiety and other psychiatric 
problems [4]. However, the pathological mechanisms of 
ODD are still unclear.
Based on DSM-IV-TR, the prevalence rate for ODD is 
2–16% [5]. Well established in previous research, this dis-
order exhibits moderate heritability, and is substantially 
stable over time, particularly through childhood [6], and 
genetic underpinning is an important factor which can 
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Familial clustering suggests an underlying genetic com-
ponent, but hereditary connections are variable [1]. ODD 
has been consistently associated with attention-deficit/
hyperactivity disorder (ADHD) [8, 9] and conduct dis-
order (CD) [10–13]. The estimated heritability of ADHD 
is approximately 0.76 [14] and 40–60% of ADHD were 
also diagnosed with ODD [15], suggesting that ODD 
might share common genetic mechanisms with ADHD 
[8]. However, the comorbidity of ODD may influence 
the clinical characteristics, progression and treatment 
response for ADHD cases [14].
Serotonin (5-HT) is a neurotransmitter involved in 
various bodily functions, such as aggression, atten-
tion, appetite and locomotion. The deficiency of the 
5-HT functions is related to depression, anxiety, irregu-
lar appetite, aggression, increased pain sensation, and 
ADHD symptoms [16]. Especially, 5-HT dysfunction 
is correlated with impulsivity, which is one of the com-
mon characteristics of ADHD, ODD, personality disorder 
[17] and substance abuse [18, 19]. Early studies reported 
a clear association between low cerebrospinal fluid 5-HT 
and impulsive aggression [20]. The conversion of trypto-
phan to 5-hydroxytryptophan is the first and rate limit-
ing step in 5-HT synthesis catalyzed by two subtypes of 
the enzyme tryptophan hydroxylase (TPH-1 and TPH-2); 
5-HT is then formed by decarboxylation of 5-hydroxy-
tryptophan. The studies revealed differential expression 
of classical TPH-1 synthesizing 5-HT in peripheral tis-
sues, and TPH-2 synthesizing 5-HT mainly in seroton-
ergic neurons of the midbrain raphe [21]. In mice brain 
stems, the expression of TPH-1 appears to be 150 times 
lower than TPH-2 [21], suggesting that TPH-2 may play 
a much more important role in serotonin synthesis in the 
brain than TPH-1. Thus, the studies have focused on the 
role of brain-specific TPH-2 in the pathophysiology of 
various psychiatric disorders, including ADHD [16].
The human TPH-2 gene spans less than 100  kb, con-
sists of 11 exons and is located in the chromosome 
12q21.1 region. Several studies have explored the asso-
ciation between TPH-2 gene polymorphisms and ADHD. 
For example, Sheehan et al. [22] firstly reported the asso-
ciation between TPH2-rs1843809 and ADHD through 
a family study. A subsequent study reported associa-
tion between TPH2-rs4570625 or TPH2-rs11178997 
and ADHD through a family study [23]. A more recent 
study showed that a significant correlation between the 
frequencies of the rs11179027 and rs1843809 of alleles of 
TPH-2 and ADHD [16]. In addition, the TPH-2 gene pol-
ymorphism have been found to be associated with late-
onset depression [24], PTSD [25, 26], suicide in patients 
with alcohol dependence [27, 28] and suicidal behavior 
[29], as well as with schizophrenia [30, 31] and panic in 
bipolar disorders [32] in the Chinese Han population.
In view of the possible shared common genes between 
ADHD and ODD, the important role of TPH-2 in 5-HT 
synthesis in brain and the possible association between 
TPH-2 gene polymorphisms and ADHD, as well as the 
associations of the TPH-2 gene polymorphism with 
behavioral and psychiatric disorders in previous studies, 
it would be of interest to examine the association between 
TPH-2 gene polymorphisms and ODD, which, to our best 
knowledge, has not been reported. Therefore, the main 
purpose of the current study was to examine whether the 
TPH-2 gene polymorphisms was associated with the sus-
ceptibility to ODD in a Chinese Han population.
Methods
Subjects
Using the random group sampling method, 2000 Chi-
nese Han students in primary school in Nanyang, Henan 
Province, China were assessed with Conners Teachers 
Rating Scale between 2007 and 2009, all four grandpar-
ents and both parents of each child were known to be of 
Han Chinese origin. To confirm the diagnosis of ODD, 
one or both parents and teachers were interviewed by 
a chief physician and resident physician on the basis of 
DSM-IV diagnostic criteria. Inclusion criteria were: 
(a) aged 6–14  years; (b) had ODD symptoms at least 
6  months; (c) intelligence quotient (IQ) ≥70 based on 
Raven’s Progressive Matrices; (d) no physical diseases, 
mental retardation, low body mass index (BMI, <18.5 kg/
m2) or other mental illnesses, or ADHD or CD symp-
toms. A total of 125 children were confirmed with ODD 
diagnosis. Among them, 124 subjects were enrolled in 
the study, including 70 boys (56.5%) and 54 girls (43.5%) 
with an average age of 10.4 ± 1.9 years.
Data also consisted of 152 control subjects (boy/
girl = 78/74), who were recruited from the same primary 
school. Mean age was 10.5 ± 1.6 years. Inclusion criteria 
were: (a) aged 6–14 years; (b) no any ODD symptoms; (c) 
intelligence quotient (IQ) ≥70 based on Raven’s Progres-
sive Matrices; (d) no physical diseases, mental retarda-
tion, low body mass index (BMI, <18.5  kg/m2) or other 
mental illnesses, or ADHD or CD symptoms.
There was no significant differences in gender, age 
and education between ODD and control groups (all 
P > 0.05). This study was approved by the Ethical Com-
mittee of the Second Affiliated Hospital, Xinxiang Medi-
cal College, Henan Province. Informed consent was 
obtained from all subjects and their parents.
TPH‑2 genotyping
5  ml blood samples were collected from cubital vein 
between 8:00 and 9:00 a. m. following an overnight fast 
and placed into the tubes with EDTA anticoagulant. Sam-
ples were stored at −70 °C until assayed.
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DNA was extracted using a Genomic DNA extraction 
kit (DP318) (TIANGEN biotechnology company, Beijing, 
China). The DNA was amplified by polymerase chain 
reaction (PCR) methods and the primers for the four loci 
(rs4570625, rs11178997, rs1386494 and rs7305115) were 
designed by Invitrogen Corporation (Shanghai, China). 
Oligonucleotide sequences are presented in Table 1.
The total volume of the PCR reaction was 30 μl which 
contained 0.5  μl whole genome DNA (50  ng/μl), 3  μl 
10× PCR buffer solution, 0.5 μl 10 mm L−1 dNTPs, 0.5 μl 
each primer, 0.3  μl Taq polymerase, 1.5  μl 25  mm  L−1 
MgCl2, and 23.7 μl sterile water. Loop parameters for PCR 
were as follows: initial denaturation at 95  °C for 5  min, 
amplification at 94 °C for 30 s, annealing at 54/56 °C for 
45  s, and extension at 72  °C for 45  s. The process was 
repeated 34 times, followed by extension at 72  °C for 
5  min. PCR products were placed onto glass slides dis-
posed with acrylamide by a Pixsys5500 microarrayer 
(Cartesian Products, Inc. America) [33]. The PCR prod-
ucts were hybridized with fluorescence-labeled probes at 
37  °C for 5–6 h, and the glass slides were scanned with 
a LuxScan-10k confocal scanner (Capitalbio Corpora-
tion, Beijing, China). The genotype of each sample was 
detected based on the fluorescent signals [34].
Statistical analysis
Differences between genotype groups were analyzed 
using Chi squared for categorical variables and the Stu-
dent’s t test or one-way analysis of variance (ANOVA) for 
continuous variables using the PASW Statistics 18.0 soft-
ware (SPSS Inc., Chicago, IL, USA).
Deviation from the Hardy–Weinberg equilibrium 
(HWE) was tested separately in cases and controls using 
Chi square (χ2) goodness-of-fit test. The difference in the 
allele and genotype frequencies for TPH-2 polymorphisms 
between ODD and normal controls was analyzed using 
the χ2 test. Pairwise linkage disequilibrium (LD) between 
four TPH-2 markers was analyzed in cases and normal 
controls. Haploview 4.2 was used to compute pairwise 
LD statistics for markers, haplotype block, haplotype fre-
quency, and haplotype association. We used a 2–4-win-
dow fashion analysis. Rare haplotypes found in less than 
3% were excluded from the association analysis. A logistic 
regression analysis was conducted to examine the inde-
pendent association of each haplotype on the categorical 
diagnosis of case (0: control, 1: case) after adjusting for the 
confounders. To control haplotype analyses for multiple 
testing, 10,000 permutations were performed for the most 
significant tests to determine the empirical significance.
The power (power defined as the chance that true dif-
ferences will actually be detected) of the sample was 
calculated using Quanto Software [35], with known risk 
allele frequencies and an ODD population prevalence of 




The genotype and allele frequencies of four SNPs located 
in the TPH-2 gene are summarized in Table 6. No devia-
tion from HWE was detected in the cases or controls (all 
P > 0.05; Tables 2, 3, 4, 5). Significant differences in the 
genotype and allele frequencies between cases and con-
trols were observed for rs1386494 (genotype χ2 = 4.163, 
P =  0.041; allele χ2 =  3.930, P =  0.047). The frequency 
of the Gallele of rs1386494 was higher in patients than 
in controls. There was no allelic or genotypic associa-
tion between the other three SNPs and ODD (all P > 0.05, 
Table 6).
Linkage disequilibrium (LD) analysis
LD analyses were performed for all polymorphism pairs 
in both case and control subjects. All four polymor-
phisms were in slight to modest LD or without LD with 
each other in both control (D′ =  0.12–0.92; r2 =  0.02–
0.71) and patient groups (D′ = 0.10–0.76; r2 = 0.00–0.16) 
(Fig. 1).
Haplotype analysis
Two–four SNP sliding window haplotype analyses were 
performed. Only those haplotypes with a frequency 
above 3% were included in the analyses. Estimation of 
haplotype frequencies and comparison of haplotype fre-
quency distributions between cases and controls were 
conducted using the program Haploview.
We observed significant differences in the frequencies 
of TA (P = 0.014, OR = 1.951, 95% CI 1.140–3.341) and 
GA (P =  0.012, OR =  0.149, 95% CI 0.027–0.826) hap-
lotypes containing rs4570625-rs11178997 between case 
and control groups.
Also, we noted significant differences in the frequen-
cies of TAG (P = 0.02, OR = 1.896, 95% CI 1.099–3.272) 
Table 1 Primer sequences of these four loci
Sequences of the four primers
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Table 2 rs4570625 Hardy–Weinberg Equilibrium test between ODD and control group
df = 1
Group Genotype
GG GT TT Total χ2 P
ODD group 1.474 0.225
Observation (O) 27 51 38 116
Expectation (E) 23.761 57.478 34.761 116
Control group 1.301 0.254
Observation (O) 36 83 33 152
Expectation (E) 39.515 75.970 36.51 152
Table 3 rs11178997 Hardy–Weinberg equilibrium test between ODD and control group
df = 1, when E is little than 5, we use Yates corrected Chi squared test, χ2*
Group Genotype
AA AT TT Total χ2 χ2* P
ODD group 1.292 0.256
 Observation (O) 6 33 84 123
 Expectation (E) 4.116* 36.768 82.116 123
Control group 0.052 0.820
 Observation (O) 4 39 109 152
 Expectation (E) 3.633* 39.734 108.63 152
Table 4 rs1386494 Hardy–Weinberg equilibrium test between ODD and control group
df = 1* when E is little than 5, we use Yates corrected Chi squared test, χ2*
Group Genotype
AA AG GG Total χ2 χ2* P
ODD group 0.138 0.711
 Observation (O) 0 8 116 124
 Expectation (E) 0.129* 7.742 116.129 124
Control group 0.856 0.355
 Observation (O) 0 21 128 149
 Expectation (E) 0.740* 19.520 128.740 149
Table 5 rs7305115 Hardy–Weinberg equilibrium test between ODD and control group
df = 1
Group AA AG GG Total χ2 P
ODD group 3.389 0.533
 Observation (O) 34 56 29 119
 Expectation (E) 32.303 59.395 27.302 119
Control group 0.844 0.358
 Observation (O) 35 64 40 139
 Expectation (E) 2.295 69.410 37.295 139
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and GAG (P = 0.013, OR = 0.149, 95% CI 0.027–0.831) 
containing rs4570625-rs11178997-rs1386494, as well as 
TAA (P = 0.026, OR = 2.315, 95% CI 1.088–4.927) con-
taining rs4570625-rs11178997-rs7305115 between case 
and control groups.
Finally, we found significant differences in the frequen-
cies of TAGA (P = 0.005, OR = 3.187, 95% CI 1.376–7.382) 
containing rs4570625-rs11178997-rs1386494-rs7305115 
between ODD and control groups (Tables 7, 8).
However, the further analysis by Haploview revealed 
the nominally significant finding for rs1386494 
(χ2  =  3.846, P  =  0.0499), and only one haplotypes 
(TAGA, χ2  =  4.366, P  =  0.0367) remained significant. 
However, the results did not remain statistically sig-
nificant after 5000-fold permutation-based analysis 
incorporating all four SNPs or all the observed hap-
lotypes (adjusted both P  >  0.14). Thus, our study was 
only considered as preliminary evidence of a possible 
association.
Power analysis
This total sample had 0.10–0.47 power, 0.31–0.70 power, 
and 0.36–0.97 power for these four polymorphisms to 
detect recessive, log additive and dominant polymor-
phic inheritance in ODD with an odds ratio (OR) of 2 or 
greater (alpha = 0.05, two tailed test).
Discussion
To our knowledge, this is the first study to find an 
association between ODD and the TPH-2 gene poly-
morphism rs1386494 or the haplotype formed by this 
polymorphism and other polymorphisms. While most 
TPH-2 association studies have used individual markers, 
we used polymorphism-based haplotypes and LD analy-
sis to show that both ODD and controls shared a homo-
geneous LD pattern. This LD suggests that these variants 
segregate together in a Chinese population.
There is an extensive data consistently showing that 
decreased functions of the central 5-HT activity are 
Table 6 Genotype and allele frequency distribution of the four loci of THP-2 between two groups
* P<0.05
Locus Genotype (%) χ2 P Allele (%) χ2 P
rs4570625 GG GT TT 4.525 0.104 G T 1.729 0.189
ODD 27 (23.3) 51 (44.0) 38 (32.8) 105 (45.3) 127 (54.7)
Control 36 (23.7) 83 (54.6) 33 (21.7) 155 (51.0) 149 (49.0)
rs11178997 AA AT TT 1.092 0.579 A T 0.783 0.376
ODD 6 (4.9) 33 (26.8) 84 (68.3) 45 (18.3) 201 (81.7)
Control 4 (2.6) 39 (25.7) 109 (71.7) 47 (15.5) 257 (84.5)
rs1386494 AA AG GG 4.163 0.041* A G 3.930 0.047*
ODD 0 8 (6.5) 116 (93.5) 8 (3.2) 240 (96.8)
Control 0 21 (14.1) 128 (85.9) 21 (7.0) 277 (93.0)
rs7305115 AA AG GG 0.756 0.685 A G 0.780 0.377
ODD 34 (28.6) 56 (47.1) 29 (24.4) 124 (52.1) 114 (47.9)
Control 35 (25.2) 64 (46.0) 40 (28.8) 134 (48.2) 144 (51.8)
Fig. 1 Genomic structure of TPH‑2, including relative location of 4 SNPs studied and linkage disequilibrium (LD) of these four SNPs in the opposi‑
tional defiant disorder (ODD) and control groups. The LD between pairwise SNPs, using D′ (left, red color) and r2 (right, gray color) values, are shown 
separately for cases and controls. High levels of LD are represented by increasing scale intensity from 0 to 100, as shown by the bars
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associated with uncontrolled behaviors, including impul-
sive behavior, aggressiveness, and substance abuse both 
in humans and in animal models, for example [29, 36, 
37]. TPH-2, a rate-limiting enzyme in the biosynthesis 
of 5-HT, is expressed mainly in brain [38]; thus, it influ-
ences the 5-HT level in brain and plays an important 
role in the development of mental disease [16]. Genetic 
variation in TPH-2 activity is likely to represent a critical 
factor in the pathogenesis of ADHD and impulsivity [16, 
23]. Several studies have demonstrated that changes in 
the 5-HT system were critical in children with ODD [39, 
40]. Moreover, the polymorphisms of TPH-2 have been 
shown to be associated with ADHD [16, 41, 42], obses-
sive–compulsive disorder [43], and bipolar affective dis-
order [44]. Also, TPH-2 was found to be associated with 
major depression [45] and pathogenesis of depression in 
Chinese females [46] and suicidal behavior [47, 48]. How-
ever, there has been no study reporting the relationship 
between TPH-2 and ODD.
This study is a case–controlled study in which the 
frequency of the genotypes and alleles of TPH-2 poly-
morphisms were compared between the ODD children 
and the control group in Chinese Han. The association 
between the genotypes and alleles of four candidates 
TPH-2 SNPs was investigated. Our results showed that 
there was a significant correlation between the fre-
quencies of the TPH-2-rs1386494 and ODD, but not 
other three polymorphisms, suggesting that the locus of 
rs1386494 of TPH-2 was associated with ODD in Chinese 
Han children. The association of TPH-2-rs1386494 in this 
study was inconsistent with the result of Walitza et  al. 
[23] study, in which loci of rs4570625 and rs11178997 
were found to be associated with ADHD and combined 
ADHD and ODD, but not rs4565946. There are several 
reasons to explain the inconsistent results. First, the sub-
jects in Walitza’s study included both ADHD and ODD. 
Second, the linkage disequilibrium analysis in the core 
family was used in Walitza’s study while the case-control 
association was used in several studies including our cur-
rent study. Thus, the differential analysis methods and 
different samples may contribute to discrepant results.
Haplotypes can be more specific risk markers than 
single alleles, and their use reduces false-positive asso-
ciations that can occur because common psychiatric 
disorders are likely to associate with common alleles 
[49]. Since the four markers analyzed were in the same 
haplotype block, we performed the two–four SNP slid-
ing window haplotype analysis [50]. We found that the 
frequencies of the TA and GA haplotypes containing 
rs4570625-rs11178997, the TAG and GAG haplotypes 
containing rs4570625-rs11178997-rs1386494, the TAA 
haplotype containing rs4570625-rs11178997-rs7305115, 
and the TAGA haplotype containing rs4570625-
rs11178997-rs1386494-rs7305115 were significantly 
Table 7 Analysis of genetic linkage disequilibrium of the four loci
SNP1:rs4570625; SNP2:rs11178997; SNP3:rs1386494; SNP4:rs7305115
SNPs SNP2 SNP3 SNP4
D′ r2 D′ r2 D′ r2
SNP1 0.702 0.090 0.093 0.001 0.405 0.161
SNP2 0.653 0.005 0.001 0.000
SNP3 0.887 0.049
Table 8 Haplotype analysis of TPH-2 between two groups
SNP1:rs4570625; SNP2:rs11178997; SNP3:rs1386494; SNP4:rs7305115 * P<0.05
Haplotype distribution Case (freq) Control (freq) χ2 Fisher P OR [95% CI]
SNP1‑2
 G‑A 1.52 (0.007) 10.57 (0.042) 6.281 0.012233* 0.149 [0.027–0.826]
 T‑A 40.48 (0.174) 24.43 (0.098) 6.083 0.013679* 1.951 [1.140–3.341]
SNP1‑2‑3
 G‑A‑G 1.51 (0.007) 10.51 (0.042) 6.234 0.012562* 0.149 [0.027–0.831]
 T‑A‑G 38.73 (0.167) 24.00 (0.096) 5.409 0.020075* 1.896 [1.099–3.272]
SNP1‑2‑4
 T‑A‑A 22.24 (0.096) 10.60 (0.042) 4.981 0.025669* 2.315 [1.088–4.927]
SNP1‑2‑3‑4
 T‑A‑G‑A 21.77 (0.094) 7.79 (0.031) 8.031 0.004617* 3.187 [1.376–7.382]
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different between ODD and controls (all P < 0.05). Fur-
ther, TA, TAG, TAA and TAGA haplotypes might be 
the risk factors for ODD, while GA and GAG haplotypes 
might be protective for ODD in Chinese Han children.
Several limitations of this study should be noted. First, 
the number of subject children was small. The subjects 
of this study were 124 ODD children and 152 children 
in the control group. Since our sample size provided 
only poor statistical power, it is possible that we do see 
the false-positive results in the present study and our 
findings need to be considered cautiously. A replication 
study would be needed to include a large sample size. 
Second, although we had genotyped four polymorphisms 
in the present study, the coverage of genetic variation is 
too limited considering the total TPH-2 gene variants 
includes at least 50 polymorphisms. Therefore, it would 
be much better to use GWAS in larger samples to cap-
ture true positive results found in our present study. 
Third, the samples in our current study were only from 
local city in Henan province, China. Thus, the findings of 
this study may not be generalized for the cases of other 
racial or ethnic groups since the frequency of alleles can 
vary due to local or racial differences. Fourth, it would 
be better to use DSM-V as a reference rather than DSM-
IV. Unfortunately, we had no DSM-V when our current 
study was conducted. We will use DSM-V as a reference 
in our future investigation to remedy this shortcoming.
In summary, we report several convergent findings 
that implicate an effect of TPH-2 genotype on increased 
risk for ODD. We found a potential genetic association 
of TPH-2 with risk for ODD, especially the TPH-2 gene 
polymorphism rs1386494. Further haplotype analyses 
showed that TA, TAG, TAA and TAGA haplotypes might 
be the risk factors for ODD, while GA and GAG haplo-
types might be protective for ODD in Chinese Han chil-
dren. However, the findings in our present study remain 
preliminary due to the limited sample size and our low 
statistical power, as well as poor coverage of genetic vari-
ations in THP-2, which require replication in larger sam-






Age rs4570625 rs11178997 rs1386494 rs7305115
1 8 GT AT GG AG
2 6 TT AT GG AG
1 7 GT AT GG AG
1 8 TT AT GG AA




Age rs4570625 rs11178997 rs1386494 rs7305115
1 9 GT TT GG AA
2 7 TT TT GG AA
1 10 TT TT AG AA
1 13 TT AT GG AG
1 10 GT TT GG AG
2 10 GT TT GG AG
2 9 TT AT GG AA
2 7 GT TT GG AG
2 9 GG TT GG GG
2 10 GT TT AG AG
2 10 TT TT GG AA
1 9 GT TT GG AG
2 10 GT TT GG GG
1 8 GG TT GG GG
2 9 GG TT GG GG
1 10 GG TT GG GG
2 12 TT AA GG AG
1 10 TT AT GG AA
1 9 GG TT GG AG
2 10 GT AT GG GG
2 10 GT AT AG AA
2 9 TT AT GG AA
1 11 TT TT GG AA
1 14 TT AT GG AG
2 14 TT AA AG AG
1 12 TT TT GG AA
2 14 GT TT GG AG
2 9 GT AT GG AG
1 10 GT TT GG AG
1 11 GG TT GG AG
1 12 GG TT AG AG
1 10 TT TT GG AG
2 12 GT TT GG AG
2 12 GG TT GG AG
2 13 GT AT GG AG
1 11 GT AT AG AG
2 8 GT AT GG GG
2 8 GT TT GG AG
1 8 GT TT GG AG
2 12 GG TT GG GG
1 9 GG TT AG AA
1 11 GT TT GG AG
1 11 GT TT GG AA
1 9 TT AA GG AG
2 10 TT TT GG AA
1 7 TT TT GG AA
2 7 GT TT GG GG
1 11 GT AT GG GG
1 10 GT TT GG AG




Age rs4570625 rs11178997 rs1386494 rs7305115
2 11 GT TT GG AG
1 10 TT TT GG GG
1 11 TT TT GG AA
2 12 GT TT GG AA
2 10 GG AT GG GG
1 12 GT AT GG AG
1 14 TT TT GG GG
1 7 GG TT AG AA
2 8 TT AA GG AA
2 9 GT TT GG AA
2 12 TT TT GG AA
1 9 TT AT GG GG
1 9 GG TT GG AG
2 9 GG TT GG AG
2 12 TT AT GG GG
2 11 TT TT GG AG
1 10 GG TT GG GG
2 11 GG TT GG GG
2 10 GG TT GG AG
1 12 GT TT GG AG
2 11 GT TT GG AG
2 11 GT TT GG AG
1 9 GG TT GG GG
2 8 GT TT GG AG
1 12 GT AT GG AA
1 12 GT TT GG AA
2 7 GT AT GG AG
1 14 TT TT GG AA
1 12 GT TT GG AA
1 10 GT TT GG AG
1 12 TT TT GG AA
2 12 GG TT GG AG
1 11 TT AT GG AA
1 13 TT TT GG AG
1 14 GT TT GG AG
2 8 GG TT GG AG
1 8 GT TT GG AG
2 13 GT AT GG AG
2 10 GG TT GG GG
1 13 GG TT GG GG
2 8 GG TT GG GG
2 9 TT AA GG GG
1 8 GT TT GG AG
2 13 TT TT GG AA
1 13 GT AT GG AG
1 9 TT AT GG GG
2 11 GT TT GG GG
1 13 GG TT GG GG




Age rs4570625 rs11178997 rs1386494 rs7305115
1 10 TT AA GG AG
2 10 GT TT GG AG
1 8 GG TT GG AG
1 9 GT TT GG AA
1 9 TT AT GG AA
1 12 GG TT GG GG
2 13 TT TT GG AG
1 9 TT AT GG AG
1 10 GT TT GG AA
1 12 GT AT GG GG
1 13 GT AT GG AA
1 12 GT AT GG GG
1 13 TT TT GG AG
1 11 AT GG AA
1 12 AT GG AG
1 11 TT GG AG
2 12 TT GG
1 12 TT GG
1 11 TT GG






Age rs4570625 rs11178997 rs1386494 rs7305115
1 8 GG TT GG GG
2 7 TT TT GG AA
1 7 GT TT AG AA
2 9 GT TT GG AG
2 10 GT TT GG AG
1 9 TT TT GG AA
2 8 GT TT GG AG
1 8 GT TT AG AG
1 11 GG TT GG GG
1 9 GG TT GG GG
2 10 TT AT AG AA
2 10 GG TT GG GG
2 13 GT TT GG GG
1 11 TT TT GG AA
1 13 TT TT GG GG
2 7 GT TT GG AG
1 12 GT TT GG AG
1 14 GT AT GG AA
1 10 GG TT AG AA
1 12 GT TT GG GG
2 12 TT AT GG AG
2 11 GG TT AG AG
2 11 GG TT GG GG




Age rs4570625 rs11178997 rs1386494 rs7305115
2 9 GG TT GG AA
2 11 GT TT GG AG
2 12 GT AT GG AA
2 10 GT TT GG AA
1 13 GT TT GG AA
1 9 GG TT GG GG
1 9 GT TT GG AG
1 8 GT TT GG AA
2 7 TT AT GG AG
2 10 TT TT GG AA
1 11 GT TT AG AG
1 12 GT TT GG AA
2 10 GG TT GG GG
1 12 TT AT GG AG
2 11 TT TT GG GG
2 11 GG TT GG AG
2 11 GG TT GG AG
1 11 GG TT GG GG
2 12 TT TT GG GG
2 10 GT AT GG AA
1 9 GG TT AG AG
1 11 GT TT GG AG
2 12 GG AA GG AG
1 12 GT AT GG GG
2 12 GT TT GG AG
2 12 GT TT GG AG
2 9 GT TT GG GG
1 9 GT TT GG AG
1 11 TT AA GG AG
2 14 GT TT GG AG
1 12 GG TT GG AG
1 12 GT AT GG AG
1 12 TT TT GG AA
1 11 GG TT GG AG
1 12 GT TT GG AG
1 12 GG AT GG AG
1 12 GT AT GG GG
1 12 TT TT GG AG
1 12 TT TT GG AA
1 12 GG AT GG AG
1 11 GT AT GG AG
1 10 GG TT GG GG
2 11 GT AT GG GG
2 13 GT TT GG AA
2 13 GT TT GG AG
2 12 TT AT GG AG
2 13 TT TT GG GG
2 12 GG TT GG GG




Age rs4570625 rs11178997 rs1386494 rs7305115
2 10 GG TT GG GG
1 10 GT TT GG AA
2 10 TT AT AG AA
2 11 GT TT AG AA
2 10 GT AT GG AG
2 10 GT AT GG AG
2 9 GT TT GG AG
2 10 GG TT GG GG
2 9 TT AT GG AA
2 10 GT AT GG GG
2 10 TT TT GG AA
1 8 GT TT GG AG
1 9 TT TT AG AA
2 10 TT TT GG GG
2 9 GT TT GG AG
1 10 GT AT AG AG
1 11 TT TT AG AG
1 12 GT TT GG AG
2 13 GT TT GG AA
2 10 GG TT GG AG
2 11 GT AT GG GG
1 11 GT TT AG AG
2 11 TT TT GG AA
1 11 GT TT GG AG
2 13 GG TT GG AG
1 13 TT TT GG AG
2 13 GT TT GG AG
1 11 TT AT GG AG
2 10 GG TT GG GG
2 8 GT TT GG AG
2 9 GT TT GG AG
1 9 GT AT GG GG
1 10 GT AT GG GG
1 11 GT TT GG AG
1 10 GT AT GG AG
1 11 GT AT GG AG
2 10 GG TT GG GG
1 9 GT TT AG AA
2 12 GT AA GG AG
2 12 GT TT GG AG
1 11 GT TT GG AG
1 7 GT TT GG AG
1 10 TT TT GG AA
1 8 GG TT GG GG
1 11 GT TT GG AG
2 13 GG TT GG GG
1 12 GG AT GG AA
1 10 GG TT GG AA
1 10 GT TT GG GG




Age rs4570625 rs11178997 rs1386494 rs7305115
2 8 GT TT GG AG
2 8 GT AT AG AG
1 12 GG TT GG GG
1 12 GG TT GG GG
2 7 TT TT GG AG
1 7 GT TT AG GG
2 9 GT AT GG GG
2 10 GT AT AG AG
1 9 TT TT GG AA
2 10 GT AT GG GG
1 8 GT AT AG GG
1 11 GG TT GG GG
1 9 GG AT GG AA
2 10 TT TT AG AA
2 10 GT TT GG GG
2 13 GT TT GG AG
1 11 TT AT GG AG
1 11 TT TT AG AA
2 7 GT TT GG
1 12 GT TT GG
1 11 GT AT GG
1 10 GT TT GG
1 12 GT AT GG
1 12 TT AT GG
2 11 GT AT GG
1 11 GT AT GG
2 9 GG TT GG
1 11 GT TT GG
2 12 GT TT
2 10 GT TT
1 8 GT AA
Abbreviations
ODD: oppositional defiant disorder; CD: conduct disorder; ADHD: attention‑
deficit/hyperactivity disorder; TPH‑2: the tryptophan hydroxylase‑2 gene; 5‑HT: 
serotonin; IQ: intelligence quotient; PCR: polymerase chain reaction; SNP: 
single nucleotide polymorphisms.
Authors’ contributions
C‑HW and CL contributed equally for this study and are both considered 
as first authors, they created the design of the study and the experimental 
paradigm, managed the acquisition of the data, analyzed and interpreted 
the data, and wrote the first draft. E‑ZC, G‑LX and T‑TL has been involved in 
collecting study subjects. Y‑LZ did the guidance of laboratory methods in this 
study, Q‑FN managed the acquisition of the data, analyzed and interpreted 
the data as an assistant, J‑KW has been involved in drafting and revising the 
manuscript. YL and H‑YN are the corresponding authors and have contributed 
equally to this work. All authors read and approved the final manuscript.
Acknowledgements
We warmly thank the children and their parents who kindly took part in this 
research, as well as the schools and the teachers who agreed to collaborate 
in this study. We warmly thank Xiang Yang Zhang to help us modify our 
language errors.
Competing interests
The related authorities and the authors declare that they all have no compet‑
ing interest. The authors declare that the research was conducted in the 
absence of any commercial, financial (and non‑financial) relationships that 
could be construed as a potential competing interests.
Consent for publication
We have obtained the informed consent for publication from the children’s 
parents or legal guardian.
Ethics approval and consent to participate
Research programs “Association of tryptophan hydroxylase‑2 polymorphisms 
with oppositional defiant disorder in a Chinese Han population” have been 
investigated by medical ethics committee of The second affiliated hospital 
of Xinxiang Medical University, which result was agreement (Batch number: 
20090108).
Funding
This work was supported by grants from the Medical Technology Foundation 
of Henan Province (142300410025 and 112102310211), Scientific Research 
Fund of Xinxiang Medical University (2013ZD117) and Ministry of Health 
research fund projects in China (20090103). Henan Provincial Department of 
Science and Technology Research Project (102101310400).
Received: 13 June 2016   Accepted: 4 November 2016
References
 1. Riley M, Ahmed S, Locke A. Common questions about oppositional defi‑
ant disorder. Am Fam Physician. 2016;93(7):586–91.
 2. Frick PJ, Nigg JT. Current issues in the diagnosis of attention defi‑
cit hyperactivity disorder, oppositional defiant disorder, and con‑
duct disorder. Annu Rev Clin Psychol. 2012;8:77–107. doi:10.1146/
annurev‑clinpsy‑032511‑143150.
 3. Cavanagh M, Quinn D, Duncan D, Graham T, Balbuena L. Oppo‑
sitional defiant disorder is better conceptualized as a disorder of 
emotional regulation. J Atten Disord. 2014;[Epub ahead of print]. 
doi:10.1177/1087054713520221.
 4. Bradshaw CP, Schaeffer CM, Petras H, Ialongo N. Predicting negative 
life outcomes from early aggressive‑disruptive behavior trajectories: 
gender differences in maladaptation across life domains. J Youth Adolesc. 
2010;39(8):953–66. doi:10.1007/s10964‑009‑9442‑8.
 5. Gomez R, Hafetz N, Gomez RM. Oppositional defiant disorder: prevalence 
based on parent and teacher ratings of Malaysian primary school chil‑
dren. Asian J Psychiatry. 2013;6(4):299–302. doi:10.1016/j.ajp.2013.01.008.
 6. Pihlakoski L, Sourander A, Aromaa M, Rautava P, Helenius H, Sillanpää M. 
The continuity of psychopathology from early childhood to preadoles‑
cence: a prospective cohort study of 3 to 12‑year‑old children. Eur Child 
Adolesc Psychiatry. 2006;15(7):409–17. doi:10.1007/s00787‑006‑0548‑1.
 7. Burke JD, Loeber R, Birmaher B. Oppositional defiant disorder and conduct 
disorder: a review of the past 10 years, part II. J Am Acad Child Adolesc 
Psychiatry. 2002;41:1275–93. doi:10.1097/01.CHI.0000024839.60748.E8.
 8. Tuvblad C, Zheng M, Raine A, Baker LA. A common genetic factor 
explains the covariation among ADHD ODD and CD symptoms in 
9–10 year old boys and girls. J Abnorm Child Psychol. 2009;37(2):153–67. 
doi:10.1007/s10802‑008‑9278‑9.
 9. Gopin CB, Berwid O, Marks DJ, Mlodnicka A, Halperin JM. ADHD pre‑
schoolers with and without ODD: do they act differently depending on 
degree of task engagement/reward? J Atten Disord. 2013;17(7):608–19. 
doi:10.1177/1087054711432140.
 10. Liu L, Cheng J, Li H, Yang L, Qian Q, Wang Y. The possible involvement of 
genetic variants of NET1 in the etiology of attention‑deficit/hyperactivity 
disorder comorbid with oppositional defiant disorder. J Child Psychol 
Psychiatry. 2015;56(1):58–66. doi:10.1111/jcpp.12278.
 11. Rowe R, Costello EJ, Angold A, Copeland WE, Maughan B. Developmen‑
tal pathways in oppositional defiant disorder and conduct disorder. J 
Abnorm Psychol. 2010;119(4):726–38. doi:10.1037/a0020798.
Page 11 of 12Wang et al. Behav Brain Funct  (2016) 12:30 
 12. Coolidge FL, Thede LL, Young SE. Heritability and the comorbidity of 
attention deficit hyperactivity disorder with behavioral disorders and 
executive function deficits: a preliminary investigation. Dev Neuropsy‑
chol. 2000;17(3):273–87. doi:10.1207/s15326942dn1703_1.
 13. Lahey BB, Waldman ID. Annual research review: phenotypic and causal 
structure of conduct disorder in the broader context of prevalent forms 
of psychopathology. J Child Psychol Psychiatry. 2012;53(5):536–57. 
doi:10.1111/j.1469‑7610.2011.02509.x.
 14. Faraone SV, Mick E. Molecular genetics of attention deficit hyperactiv‑
ity disorder. Psychiatr Clin North Am. 2010;33(1):159–80. doi:10.1016/j.
psc.2009.12.004.
 15. Dittmann RW, Schacht A, Helsberg K, Schneider‑Fresenius C, Lehmann M, 
Lehmkuhl G, Wehmeier PM. Atomoxetine versus placebo in children and 
adolescents with attention‑deficit/hyperactivity disorder and comorbid 
oppositional defiant disorder: a double‑blind, randomized, multicenter 
trial in Germany. J Child Adolesc Psychopharmacol. 2011;21(2):97–110. 
doi:10.1089/cap.2009.0111.
 16. Park TW, Park YH, Kwon HJ, Lim MH. Association between TPH2 gene poly‑
morphisms and attention deficit hyperactivity disorder in Korean children. 
Genet Test Mol Biomark. 2013;17(4):301–6. doi:10.1089/gtmb.2012.0376.
 17. Marazziti D, Baroni S, Masala I, Golia F, Consoli G, Massimetti G, Picchetti M, 
Catena Dell’osso M, Giannaccini G. Impulsivity, gender, and the platelet sero‑
tonin transporter in healthy subjects. Neuropsychiatr Dis Treat. 2010;6:9–15.
 18. Brewer JA, Potenza MN. The neurobiology and genetics of impulse 
control disorders: relationships to drug addictions. Biochem Pharmacol. 
2008;75(1):63–75. doi:10.1016/j.bcp.2007.06.043.
 19. Coccaro EF, Lee R. Cerebrospinal fluid 5‑hydroxyindolacetic acid and homo‑
vanillic acid: reciprocal relationships with impulsive aggression in human 
subjects. J Neural Transm. 2010;117(2):241–8. doi:10.1007/s00702‑009‑0359‑x.
 20. Glick A. The role of serotonin in impulsive aggression, suicide, and 
homicide in adolescents and adults: a literature review. Int J Adolesc Med 
Health. 2015;27(2):143–50. doi:10.1515/ijamh‑2015‑5003.
 21. Walther DJ, Bader M. A unique central tryptophan hydroxylase 
isoform. Biochem Pharmacol. 2003;66(9):1673–80. doi:10.1016/
S0006‑2952(03)00556‑2.
 22. Sheehan K, Lowe N, Kirley A, Mullins C, Fitzgerald M, Gill M, Hawi Z. Tryp‑
tophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol 
Psychiatry. 2005;10(10):944–9. doi:10.1038/sj.mp.4001698.
 23. Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer Ch, Halbach A, 
Herpertz‑Dahlmann B, Remschmidt H, Smidt J, Linder M, Flierl L, Knölker 
U, Friedel S, Schäfer H, Gross C, Hebebrand J, Warnke A, Lesch KP. 
Transmission disequilibrium of polymorphicvariants in the tryptophan 
hydroxylase‑2 gene in attention‑deficit/hyperactivity disorder. Mol 
Psychiatry. 2005;10(12):1126–32. doi:10.1038/sj.mp.4001734.
 24. Pereira Pde A, Romano‑Silva MA, Bicalho MA, De Marco L, Correa H, 
de Campos SB, de Moraes EN, Torres KC, de Souza BR, de Miranda DM. 
Association between tryptophan hydroxylase‑2 gene and late‑onset 
depression. Am J Geriatr Psychiatry. 2011;19(9):825–9. doi:10.1097/
JGP.0b013e31820eeb21.
 25. Goenjian AK, Bailey JN, Walling DP, Steinberg AM, Schmidt D, Dandekar 
U, Noble EP. Association of TPH1, TPH2, and 5HTTLPR with PTSD and 
depressive symptoms. J Affect Disord. 2012;140(3):244–52. doi:10.1016/j.
jad.2012.02.015.
 26. Goenjian AK, Noble EP, Steinberg AM, Walling DP, Stepanyan ST, Dan‑
dekar S, Bailey JN. Association of COMT and TPH‑2 genes with DSM‑5 
based PTSD symptoms. J Affect Disord. 2014;172C:472–8. doi:10.1016/j.
jad.2014.10.034.
 27. Wrzosek M, Łukaszkiewicz J, Wrzosek M, Serafin P, Jakubczyk A, Klimk‑
iewicz A, Matsumoto H, Brower KJ, Wojnar M. Association of polymor‑
phisms in HTR2A, HTR1A and TPH2 genes with suicide attempts in alcohol 
dependence: a preliminary report. Psychiatry Res. 2011;190(1):149–51. 
doi:10.1016/j.psychres.2011.04.027.
 28. Zupanc T, Pregelj P, Paska AV. Tryptophan hydroxylase 2 (TPH‑2) single 
nucleotide polymorphisms, suicide, and alcohol‑related suicide. Psychiatr 
Danub. 2013;25(Suppl 2):332–6.
 29. Perez‑Rodriguez MM, Weinstein S, New AS, Bevilacqua L, Yuan Q, Zhou 
Z, Hodgkinson C, Goodman M, Koenigsberg HW, Goldman D, Siever LJ. 
Tryptophan‑hydroxylase 2 haplotype association with borderline per‑
sonality disorder and aggression in a sample of patients with personality 
disorders and healthy controls. J Psychiatr Res. 2010;44(15):1075–81. 
doi:10.1016/j.jpsychires.
 30. Zhang C, Li Z, Shao Y, Xie B, Du Y, Fang Y, Yu S. Association study of tryp‑
tophan hydroxylase‑2 gene in schizophrenia and its clinical features in 
Chinese Han population. J Mol Neurosci. 2011;43(3):406–11. doi:10.1007/
s12031‑010‑9458‑2.
 31. Xu XM, Ding M, Pang H, Wang BJ. TPH2 gene polymorphisms in the regulatory 
region are associated with paranoid schizophrenia in Northern Han Chinese. 
Genet Mol Res. 2014;13(1):1497–507. doi:10.4238/2014.March.12.1.
 32. Campos SB, Miranda DM, Souza BR, Pereira PA, Neves FS, Tramontina J, 
Kapczinski F, Romano‑Silva MA, Correa H. Association study of trypto‑
phan hydroxylase 2 gene polymorphisms in bipolar disorder patients 
with panic disorder comorbidity. Psychiatr Genet. 2011;21:106–11. 
doi:10.1097/YPG.0b013e328341a3a8.
 33. Xiao PF, Cheng L, Wan Y, Sun BL, Chen ZZ, Zhang SY, Zhang CZ, Zhou 
GH, Lu ZH. An improved gel‑based DNA microarray method for detect‑
ing single nucleotide mismatch. Electrophoresis. 2006;27(19):3904–15. 
doi:10.1002/elps.200500918.
 34. Xiao P, Huang H, Zhou G, Lu Z. Gel immobilization of acrylamide‑modi‑
fied single‑stranded DNA template for pyrosequencing. Electrophoresis. 
2007;28(12):1903–12. doi:10.1002/elps.200600794.
 35. Gauderman WJ. Sample size requirements for association studies of 
gene‑gene interaction. Am J Epidemiol. 2002;155(5):478–84.
 36. Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Jiménez M, Galleguillos F, Bus‑
tamante ML. Fluoxetine response in impulsive‑aggressive behavior and 
serotonin transporter polymorphism in personality disorder. Psychiatr 
Genet. 2010;20(1):25–30. doi:10.1097/YPG.0b013e328335125d.
 37. Audero E, Mlinar B, Baccini G, Skachokova ZK, Corradetti R, Gross 
C. Suppression of serotonin neuron firing increases aggres‑
sion in mice. J Neurosci. 2013;33(20):8678–88. doi:10.1523/
JNEUROSCI.2067‑12.2013.
 38. Chen GL, Miller GM. Advances in tryptophan hydroxylase‑2 gene 
expression regulation: new insights into serotonin‑stress interaction 
and clinical implications. Am J Med Genet B Neuropsychiatr Genet. 
2012;159B(2):152–71. doi:10.1002/ajmg.b.32023.
 39. Martel MM, Nikolas M, Jernigan K, Friderici K, Nigg JT. Diversity in path‑
ways to common childhood disruptive behavior disorders. J Abnorm 
Child Psychol. 2012;40(8):1223–36. doi:10.1007/s10802‑012‑9646‑3.
 40. Brammer WA, Lee SS. Prosociality and negative emotionality mediate the 
association of serotonin transporter genotype with childhood ADHD and 
ODD. J Clin Child Adolesc Psychol. 2013;42(6):809–19. doi:10.1080/153744
16.2013.840638.
 41. Waider J, Araragi N, Gutknecht L, Lesch KP. Tryptophan hydroxylase‑2 
(TPH2) in disorders of cognitive control and emotion regulation: a per‑
spective. Psychoneuroendocrinology. 2011;36(3):393–405. doi:10.1016/j.
psyneuen.
 42. Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Hwang JA, Kim YK. A 
case‑control association study of serotonin 1A receptor gene and trypto‑
phan hydroxylase 2 gene in attention deficit hyperactivity disorder. Prog 
Neuropsychopharmacol Biol Psychiatry. 2010;34(6):974–9. doi:10.1016/j.
pnpbp.
 43. Rocha FF, Alvarenga NB, Lage NV, Romano‑Silva MA, Marco LA, Corrêa H. 
Associations between polymorphic variants of the tryptophan hydroxy‑
lase 2 gene and obsessive‑compulsive disorder. Rev Bras Psiquiatr. 
2011;33:176–80.
 44. Carkaci‑Salli N, Salli U, Tekin I, Hengst JA, Zhao MK, Gilman TL, Andrews 
AM, Vrana KE. Functional characterization of the S41Y (C2755A) polymor‑
phism of tryptophan hydroxylase 2. J Neurochem. 2014;130(6):748–58. 
doi:10.1111/jnc.12779.
 45. Gao J, Pan Z, Jiao Z, Li F, Zhao G, Wei Q, Pan F, Evangelou E. TPH2 gene 
polymorphisms and major depression–a meta‑analysis. PLoS ONE. 
2012;7(5):e36721. doi:10.1371/journal.pone.0036721.
 46. Shen X, Wu Y, Qian M, Wang X, Hou Z, Liu Y, Sun J, Zhong H, Yang J, Lin M, 
Li L, Guan T, Shen Z, Yuan Y. Tryptophan hydroxylase 2 gene is associated 
with major depressive disorder in a female Chinese population. J Affect 
Disord. 2011;133(3):619–24. doi:10.1016/j.jad.2011.04.037.
 47. Zupanc T, Pregelj P, Tomori M, Komel R, Paska AV. TPH2 polymor‑
phisms and alcohol‑related suicide. Neurosci Lett. 2011;490(1):78–81. 
doi:10.1016/j.neulet.2010.12.030.
 48. Lazary J, Viczena V, Dome P, Chase D, Juhasz G, Bagdy G. Hopeless‑
ness, a potential endophenotpye for suicidal behavior, is influenced 
by TPH2 gene variants. Prog Neuropsychopharmacol Biol Psychiatry. 
2012;36(1):155–60. doi:10.1016/j.pnpbp.2011.09.001.
Page 12 of 12Wang et al. Behav Brain Funct  (2016) 12:30 
 49. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta‑analysis 
of genetic association studies supports a contribution of common vari‑
ants to susceptibility to common disease. Nat Genet. 2003;33(2):177–82. 
doi:10.1038/ng1071.
 50. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, 
Higgins J, DeFelice M, Lochner A, Faggart M. The structure of haplo‑
type blocks in the human genome. Science. 2002;296(5576):2225–9. 
doi:10.1126/science.1069424.
